Arimidex Observational: Reason for and Effect of Change From Tamoxifen
NCT ID: NCT00246961
Last Updated: 2007-10-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2004-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hormone sensitive breast cancer
* Patient uses tamoxifen or has stopped taking tamoxifen less than 7 days ago
Exclusion Criteria
* Patients with signs of progression at the moment of changing therapy
* Patients who have used other endocrine treatments for breast cancer besides tamoxifen
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
AstraZeneca The Netherlands Medical Director, MD
Role: STUDY_DIRECTOR
AstraZeneca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
's-Hertogenbosch, , Netherlands
Research Site
Alkmaar, , Netherlands
Research Site
Antwerpen, , Netherlands
Research Site
Apeldoorn, , Netherlands
Research Site
Bergen op Zoom, , Netherlands
Research Site
Boxmeer, , Netherlands
Research Site
Breda, , Netherlands
Research Site
Doetinchem, , Netherlands
Research SIte
Dordrecht, , Netherlands
Research Site
Ede, , Netherlands
Research Site
Eindhoven, , Netherlands
Research Site
Enschede, , Netherlands
Research Site
Flushing, , Netherlands
Research Site
Geldrop, , Netherlands
Research Site
Groningen, , Netherlands
Research Site
Harderwijk, , Netherlands
Research Site
Helmond, , Netherlands
Research Site
Hoogeveen, , Netherlands
Research Site
Hoorn, , Netherlands
Research Site
Leiden, , Netherlands
Research Site
Oosterhout, , Netherlands
Research Site
Purmerend, , Netherlands
Research Site
Roermond, , Netherlands
Research Site
Roosendaal, , Netherlands
Research Site
Rotterdam, , Netherlands
Research Site
Schiedam, , Netherlands
Research Site
Terneuzen, , Netherlands
Research Site
The Hague, , Netherlands
Research Site
Tiel, , Netherlands
Research Site
Venray, , Netherlands
Research Site
Winterswijk, , Netherlands
Research Site
Zoetermeer, , Netherlands
Research Site
Zutphen, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ARREST
Identifier Type: -
Identifier Source: secondary_id
D5392NL0002
Identifier Type: -
Identifier Source: org_study_id